Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Döhner

Showing results (51-60 of 490) with videos related to

Pageof 49
Sort By:
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
Genes, Chromosomes & Cancer|September 25, 2003
Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemiaClaudia Scholl, Heike Breitinger, Richard F Schlenk, et al.
Case Reports in Medicine|April 17, 2010
Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancerJochen Greiner, Rainer Küfer, Sven N Reske, et al.
Haematologica|October 18, 2006
JAK2V617F mutations as cooperative genetic lesions in t(8;21)-positive acute myeloid leukemiaKonstanze Döhner, Juan Du, Andrea Corbacioglu, et al.
Haematologica|April 12, 2005
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13qPeter Liebisch, Susanne Eppinger, Christine Schöpflin, et al.
Critical Reviews in Oncology/Hematology|July 12, 2017
Azacitidine in adult patients with acute myeloid leukemiaAndre C Schuh, Hartmut Döhner, Lisa Pleyer, et al.
International Journal of Cancer|July 15, 2018
Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical respondersSusanne Hofmann, Michael Schmitt, Marlies Götz, et al.
American Journal of Hematology|October 31, 2022
International Consensus Classification for myeloid neoplasms at-a-glanceAttilio Orazi, Robert P Hasserjian, Mario Cazzola, et al.
Blood|April 4, 2013
Circulating microRNAs in hematological diseases: principles, challenges, and perspectivesSarah Grasedieck, Antonio Sorrentino, Christian Langer, et al.
Blood|May 16, 2002
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemiaDaniel Mertens, Stephan Wolf, Petra Schroeter, et al.
Pageof 49

Showing results (51-60 of 490) with videos related to

Sort By:
Pageof 49
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
Genes, Chromosomes & Cancer|September 25, 2003
Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemiaClaudia Scholl, Heike Breitinger, Richard F Schlenk, et al.
Case Reports in Medicine|April 17, 2010
Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancerJochen Greiner, Rainer Küfer, Sven N Reske, et al.
Haematologica|October 18, 2006
JAK2V617F mutations as cooperative genetic lesions in t(8;21)-positive acute myeloid leukemiaKonstanze Döhner, Juan Du, Andrea Corbacioglu, et al.
Haematologica|April 12, 2005
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13qPeter Liebisch, Susanne Eppinger, Christine Schöpflin, et al.
Critical Reviews in Oncology/Hematology|July 12, 2017
Azacitidine in adult patients with acute myeloid leukemiaAndre C Schuh, Hartmut Döhner, Lisa Pleyer, et al.
International Journal of Cancer|July 15, 2018
Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical respondersSusanne Hofmann, Michael Schmitt, Marlies Götz, et al.
American Journal of Hematology|October 31, 2022
International Consensus Classification for myeloid neoplasms at-a-glanceAttilio Orazi, Robert P Hasserjian, Mario Cazzola, et al.
Blood|April 4, 2013
Circulating microRNAs in hematological diseases: principles, challenges, and perspectivesSarah Grasedieck, Antonio Sorrentino, Christian Langer, et al.
Blood|May 16, 2002
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemiaDaniel Mertens, Stephan Wolf, Petra Schroeter, et al.
Pageof 49